Pipeline
Focused on the development of cutting-edge technologies and innovative products in the field of obesity, with a commitment to building an integrated platform that spans from discovery to commercialization.
Advancing multiple innovative drug projects in the fields of neurodegenerative diseases, oncology, and metabolism, currently progressing into the preclinical development stage.
